Ident. | Authors (with country if any) | Title |
---|
000042 (2019) |
M. Linster [Pays-Bas, Singapour] ; E. J. A. Schrauwen [Pays-Bas] ; S. Van Der Vliet [Pays-Bas] ; D. F. Burke [Royaume-Uni] ; P. Lexmond [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; D. J. Smith [Royaume-Uni] ; S. Herfst [Pays-Bas] ; B. F. Koel [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas] | The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses |
000087 (2019) |
Z Beau Reneer [États-Unis] ; Ted M. Ross [États-Unis] | H2 influenza viruses: designing vaccines against future H2 pandemics. |
000143 (2018) |
Ji-Eun Park [Corée du Sud] ; Yeonhee Ryu [Corée du Sud] | Transmissibility and severity of influenza virus by subtype. |
000166 (2018) |
Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik Peiris | Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment |
000168 (2018) |
Alain Gagnon [Canada] ; Enrique Acosta [Canada] ; Stacey Hallman [Canada] ; Robert Bourbeau [Canada] ; Lisa Y. Dillon [Canada] ; Nadine Ouellette [Canada] ; David J. D. Earn [Canada] ; D. Ann Herring [Canada] ; Kris Inwood [Canada] ; Joaquin Madrenas [États-Unis] ; Matthew S. Miller [Canada] | Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic |
000214 (2018) |
Yu-Nong Gong [Taïwan] ; Rei-Lin Kuo [Taïwan] ; Guang-Wu Chen [Taïwan] ; Shin-Ru Shih [Taïwan] | Centennial review of influenza in Taiwan |
000220 (2018) |
Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie Mignot | Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy |
000259 (2017) |
Robert P. De Vries [États-Unis, Pays-Bas] ; Wenjie Peng [États-Unis] ; Oliver C. Grant [États-Unis] ; Andrew J. Thompson [États-Unis] ; Xueyong Zhu [États-Unis] ; Kim M. Bouwman [Pays-Bas] ; Alba T. Torrents De La Pena [Pays-Bas] ; Marielle J. Van Breemen [Pays-Bas] ; Iresha N. Ambepitiya Wickramasinghe [Pays-Bas] ; Cornelis A. M. De Haan [Pays-Bas] ; Wenli Yu [États-Unis] ; Ryan Mcbride [États-Unis] ; Rogier W. Sanders [Pays-Bas, États-Unis] ; Robert J. Woods [États-Unis] ; Monique H. Verheije [Pays-Bas] ; Ian A. Wilson [États-Unis] ; James C. Paulson [États-Unis] | Three mutations switch H7N9 influenza to human-type receptor specificity |
000264 (2017) |
Nicholas Wohlgemuth [États-Unis] ; Yang Ye [États-Unis] ; Katherine J. Fenstermacher [États-Unis] ; Hsuan Liu [États-Unis] ; Andrew P. Lane [États-Unis] ; Andrew Pekosz [États-Unis] | The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. |
000274 (2017) |
Gerardo Chowell ; Lone Simonsen ; Rodrigo Fuentes ; Jose Flores ; Mark A. Miller ; Cécile Viboud | Severe mortality impact of the 1957 influenza pandemic in Chile |
000286 (2017) |
Zhu-Nan Li [États-Unis] ; Jessica F. Trost [États-Unis] ; Kimberly M. Weber [États-Unis] ; Elizabeth H. Lemasters [États-Unis] ; Sharifa Nasreen [Bangladesh] ; Javan Esfandiari [États-Unis] ; Angelo H. Gunasekera [États-Unis] ; Megan Mccausland [États-Unis] ; Katharine Sturm-Ramirez [États-Unis] ; Jens Wrammert [États-Unis] ; Sean Gregory [États-Unis] ; Vic Veguilla [États-Unis] ; James Stevens [États-Unis] ; Joseph D. Miller [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Min Z. Levine [États-Unis] | Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications. |
000305 (2017) |
Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas] | Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2) |
000318 (2017) |
Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis] | Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice |
000355 (2017) |
Troy C. Sutton [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Kevin W. Bock [États-Unis] ; Ian N. Moore [États-Unis] ; Wouter Koudstaal [Pays-Bas] ; Muniza Rehman [Pays-Bas] ; Gerrit Jan Weverling [Pays-Bas] ; Jaap Goudsmit [Pays-Bas] ; Kanta Subbarao [États-Unis] | In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice |
000406 (2016) |
Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. Weiss | Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses. |
000412 (2016) |
Alex W. H. Chin ; Hui-L. Yen ; Scott Krauss ; Richard J. Webby ; Leo L. M. Poon | Recombinant influenza virus with a pandemic H2N2 polymerase complex has a higher adaptive potential than one with seasonal H2N2 polymerase complex |
000420 (2016) |
Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde] | Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses. |
000421 (2016) |
April J. Cobos [États-Unis] ; Clinton G. Nelson [États-Unis] ; Megan Jehn [États-Unis] ; Cécile Viboud [États-Unis] ; Gerardo Chowell [États-Unis] | Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County, Arizona |
000465 (2016) |
Sergio M. Qui Ones-Parra [Australie] ; E. Bridie Clemens [Australie] ; Zhongfang Wang [Australie] ; Hayley A. Croom [Australie] ; Lukasz Kedzierski [Australie] ; Jodie Mcvernon [Australie] ; Dhanasekaran Vijaykrishna [Singapour] ; Katherine Kedzierska [Australie] | A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses |
000470 (2016) |
Naomi Komadina [Australie] ; Sergio M. Qui Ones-Parra [Australie] ; Katherine Kedzierska [Australie] ; James M. Mccaw [Australie] ; Anne Kelso [Australie] ; Karin Leder [Australie] ; Jodie Mcvernon [Australie] | High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant |
000498 (2015) |
A V Lyapunov ; S I Kolesnikov ; M A Khasnatinov ; E L Manzarova ; I V Petrova ; V V Dolgikh ; G A Danchinova | [Child and Adolescent Interepydemic Immunity to Influenza Viruses]. |
000505 (2015) |
Sarder Mohammed Asaduzzaman [Canada] ; Junling Ma [Canada] ; P. Van Den Driessche [Canada] | The coexistence or replacement of two subtypes of influenza. |
000509 (2015) |
Isabel Wendel [Allemagne] ; Dennis Rubbenstroth [Allemagne] ; Jennifer Doedt [Allemagne] ; Georg Kochs [Allemagne] ; Jochen Wilhelm [Allemagne] ; Peter Staeheli [Allemagne] ; Hans-Dieter Klenk [Allemagne] ; Mikhail Matrosovich [Allemagne] | The Avian-Origin PB1 Gene Segment Facilitated Replication and Transmissibility of the H3N2/1968 Pandemic Influenza Virus |
000513 (2015) |
Daniel Dlugolenski [États-Unis] ; Les Jones [États-Unis] ; Elizabeth Howerth [États-Unis] ; David Wentworth [États-Unis] ; S. Mark Tompkins [États-Unis] ; Ralph A. Tripp [États-Unis] | Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression |
000522 (2015) |
Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie] | Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers |
000529 (2015) |
Zhong-Wei Zhang [République populaire de Chine] ; Ting Liu [République populaire de Chine] ; Jian Zeng [République populaire de Chine] ; Yang-Er Chen [République populaire de Chine, Suède] ; Ming Yuan [République populaire de Chine, États-Unis] ; Da-Wei Zhang [République populaire de Chine, États-Unis] ; Feng Zhu [République populaire de Chine] ; Shu Yuan [République populaire de Chine] | Prediction of the next highly pathogenic avian influenza pandemic that can cause illness in humans |
000533 (2015) |
Larisa Rudenko [Russie] ; Irina Isakova-Sivak | Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. |
000549 (2015) |
Tadanobu Takahashi ; Takashi Suzuki | Low-pH Stability of Influenza A Virus Sialidase Contributing to Virus Replication and Pandemic. |
000556 (2015) |
Xiaolan Yang [République populaire de Chine] ; Jianyu Zhao [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yueqiang Duan [République populaire de Chine] ; Zhongpeng Zhao [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Liangyan Zhang [République populaire de Chine] ; Li Xing [République populaire de Chine] ; Chengcai Lai [République populaire de Chine] ; Shaogeng Zhang [République populaire de Chine] ; Xiliang Wang [République populaire de Chine] ; Penghui Yang [République populaire de Chine] | Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge. |
000561 (2015) |
Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers |
000562 (2015) |
Cécile Viboud [États-Unis] ; Lone Simonsen [États-Unis, Danemark] ; Rodrigo Fuentes ; Jose Flores [Chili] ; Mark A. Miller [États-Unis] ; Gerardo Chowell [États-Unis] | Global Mortality Impact of the 1957–1959 Influenza Pandemic |
000563 (2015) |
Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. |
000653 (2014) |
Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni] | The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency. |
000670 (2014) |
Jeremy C. Jones ; Tatiana Baranovich ; Bindumadhav M. Marathe ; Angela F. Danner ; Jon P. Seiler ; John Franks ; Elena A. Govorkova ; Scott Krauss ; Robert G. Webster | Risk Assessment of H2N2 Influenza Viruses from the Avian Reservoir |
000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
000697 (2014) |
Irina V. Alymova [États-Unis] ; Ian A. York [États-Unis] ; Jonathan A. Mccullers [États-Unis] | Non-Avian Animal Reservoirs Present a Source of Influenza A PB1-F2 Proteins with Novel Virulence-Enhancing Markers |
000750 (2014) |
Arkadiusz Wyrzucki [Suisse] ; Cyrille Dreyfus [États-Unis] ; Ines Kohler [Suisse] ; Marco Steck [Suisse] ; Ian A. Wilson [États-Unis] ; Lars Hangartner [Suisse] | Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody |
000754 (2014) |
Udayan Joseph [Singapour] ; Martin Linster [Singapour, Pays-Bas] ; Yuka Suzuki [Singapour] ; Scott Krauss [États-Unis] ; Rebecca A. Halpin [États-Unis] ; Dhanasekaran Vijaykrishna [Singapour] ; Thomas P. Fabrizio [États-Unis] ; Theo M. Bestebroer [Pays-Bas] ; Sebastian Maurer-Stroh [Singapour] ; Richard J. Webby [États-Unis] ; David E. Wentworth [États-Unis] ; Ron A. M. Fouchier [Pays-Bas] ; Justin Bahl [Singapour, États-Unis] ; Gavin J. D. Smith [Singapour, États-Unis] | Adaptation of Pandemic H2N2 Influenza A Viruses in Humans |
000804 (2013) |
Wilfried Witte | [Pandemic without drama. Influenza vaccination and Asian flu in Germany]. |
000825 (2013) |
Cyrille Dreyfus ; Damian C. Ekiert ; Ian A. Wilson | Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin |
000829 (2013) |
Hua Yang ; Paul J. Carney ; Jessie C. Chang ; Julie M. Villanueva ; James Stevens | Structural Analysis of the Hemagglutinin from the Recent 2013 H7N9 Influenza Virus |
000833 (2013) |
Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. Gray | Serological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers. |
000849 (2013) |
Rui Xu [États-Unis] ; Robert P. De Vries [États-Unis] ; Xueyong Zhu [États-Unis] ; Corwin M. Nycholat [États-Unis] ; Ryan Mcbride [États-Unis] ; Wenli Yu [États-Unis] ; James C. Paulson [États-Unis] ; Ian A. Wilson [États-Unis] | Preferential recognition of avian-like receptors in human influenza A H7N9 viruses |
000859 (2013) |
Matthew S. Miller [États-Unis] ; Thomas J. Gardner [États-Unis] ; Florian Krammer [États-Unis] ; Lauren C. Aguado [États-Unis] ; Domenico Tortorella [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Palese [États-Unis] | Neutralizing antibodies against previously-encountered influenza virus strains increase over time: A longitudinal analysis |
000864 (2013) |
Wen He [République populaire de Chine] ; Wei Wang ; Huamin Han ; Lei Wang ; Ge Zhang ; Bin Gao | Molecular basis of live-attenuated influenza virus. |
000915 (2013) |
Takayuki Komatsu [Japon] ; Nobuo Kido ; Tsuyoshi Sugiyama ; Takashi Yokochi | Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection. |
000A00 (2012) |
Yu-Jiun Chan | The threat of highly pathogenic avian influenza H5: will H5N2 infections occur in humans? |
000A04 (2012) |
Tom Reichert [États-Unis] ; Gerardo Chowell [États-Unis] ; Jonathan A. Mccullers [États-Unis] | The age distribution of mortality due to influenza: pandemic and peri-pandemic |
000A23 (2012) |
Jianzhong Shi [République populaire de Chine] ; Zhiyuan Wen ; Jing Guo ; Ying Zhang ; Guohua Deng ; Yuelong Shu ; Dayan Wang ; Yongping Jiang ; Yoshihiro Kawaoka [États-Unis] ; Zhigao Bu ; Hualan Chen | Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice. |
000A50 (2012) |
Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto Burioni | Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines |
000A62 (2012) |
Masanori Terajima ; Jenny Aurielle B. Babon ; Francis A. Ennis | Epidemiology of the Influenza A Virus H5N1 Subtype and Memory of Immunity to the H2N2 Subtype |